I appreciate all the informative posts by many on this board. Many arguments about STAR, management, and the science have been presented. As far as management, the changes with Mullan, etc., are a definate positive. Mullan and Chapman are not on board for a snakeoil product. The road to success with a pharma version of anatabine may not be as quick as people would like, but the reality is it is very possible, maybe with a fast track. Studies are there to get this approval, despite arguements to the contrary. The current version, AnataBloc, is successful in alleviating many conditions, and even though it has not flown off the shelves, it has many believers in it's benefit's, including myself. Naysayers spout many arguements, but for the most part deflect and avoid answers when questioned about the statements that they make. STAR may take off any time, or it may take years. All I know is I am recieving the benefits of AnataBloc, and am willing to wait for the benifits of the stock.
